All posts in Connecticut News

A year and a half after New Jersey residents voted to legalize cannabis, the state on Monday gave seven medical-marijuana companies approval to start selling their products to all adults, opening the door to the first legal marijuana sales in the New York City region within a month. In a meeting held by videoconference, the five-member Cannabis Regulatory Commission ushered in a seismic cultural change, making New Jersey the second state on the East Coast to fully authorize sales of cannabis to all adults. For years, the state’s medical-marijuana dispensaries had been permitted to sell cannabis only to buyers with…

An Oklahoma Senate committee on Monday unanimously approved a House-passed bill to allow for the cultivation and administration of psilocybin by eligible institutions for research purposes—but the version that senators advanced omits a broader decriminalization provision that had previously been included. The Senate Health and Human Services Committee advanced the amended legislation from Rep. Daniel Pae (R) in a 9-0 vote. The bill is a committee substitute of an earlier version that originally contained a provision to decriminalize psilocybin for unauthorized use by making it punishable by a fine without the threat of jail time. That more closely aligns the…

America’s best weed events of 420 ’22 | Leafly Link copied to your clipboard Leafly Leafly ® Loading… Where are you from? noyes Remember me for 30 days. I confirm that this is not a shared device. Darn! You’re not old enough to use Leafly. Redirecting you to By accessing this site, you accept the Terms of Use and Privacy Policy. As a weed journalist who’s curated 4/20 events for Leafly through some dark years now—holy crap, I am so happy to report that 2022 is ON. And I mean ON like never before. Adding New York, Arizona, Montana, New…

In 2019, Dr. Katherine MacLean and Brett Greene coined the term “corporadelic” to describe the corporate commodification of the psychedelic “landscape.” And they couldn’t have been more on point. There has been an explosion of renewed interest in the psychedelic space, specifically in the medical application of psychedelic substances as a therapeutic treatment for mental and emotional disorder. This has caught the eye of some of the largest names in private equity, and investor enthusiasm is not going unnoticed. Industry reporting has tracked some of these cutting-edge psychedelic bio-techs through a series of highly successful funding rounds, which have culminated…